Victor Chen, M.D.

Po-Hung Chen, M.D.

Headshot of Victor Chen
  • Assistant Professor of Medicine
Male

Expertise

Acute or Chronic Viral Hepatitis, Acute Viral Hepatitis, Alcoholic Liver Disease, Alpha 1 Antitrypsin (AAT) Deficiency, Ascites, Autoimmune Hepatitis, Benign Liver Lesions, Bile Duct Disease, Cholangiocarcinoma, Cholestatic Liver Diseases of Childhood, Cirrhosis, Clinical Gastroenterology, Elevated Liver Tests, Esophageal varices (Enlarged Veins), Fatty Liver, Gastroenterology, Hemangiomas, Hemochromatosis, Hepatic (Liver) Adenoma, Hepatic Encephalopathy, Hepatocellular Carcinoma, Hepatology, Hepatomegaly (Enlarged Liver), Jaundice, Live Donor Liver Transplant, Liver Cancer, Liver Cysts, Liver Disease, Liver Injury, Liver Mass, Liver Test Abnormalities, Liver Transplant, Liver Transplant Evaluation, Nonalcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis (NASH), Pediatric Liver Transplant, Primary Biliary Cholangitis, Sclerosing Cholangitis ...read more

Research Interests

Alcohol-associated Liver Disease; Alcohol Use Disorder; Liver Transplant; Epidemiology; Causal Inference; Qualitative Research; Health Economics/Outcomes ...read more

Locations

Johns Hopkins Medicine - Green Spring Station

2360 W. Joppa Road
Joppa Concourse Suite 205
Lutherville, MD 21093 map
Phone: 410-933-7495 | Fax: 410-367-2482

The Johns Hopkins Hospital (Main Entrance)

1800 Orleans St.
Baltimore, MD 21287 map

Background

Dr. Chen specializes in general and transplant hepatology and is an active clinician-investigator of the Johns Hopkins DELTA Center for Alcohol Research and Transplant Research Center. Dr. Chen's academic research applies epidemiologic, causal inference, and qualitative methodologies to address impactful topics in clinical hepatology. In particular, he aspires to improve the standards of care for alcohol-associated liver disease, alcohol use disorder, and liver transplantation. Dr. Chen and his team have presented their works at numerous national/international scientific conferences and medical journals.

Dr. Chen is a Ph.D. candidate in Clinical Investigation at the Johns Hopkins School of Medicine and the Johns Hopkins Bloomberg School of Public Health. He completed the certificate program in Public Health Economics at the Johns Hopkins Bloomberg School of Public Health in 2021. In addition, he received the INGUIDE Level 1: Guideline Group or Panel Member certification from Guidelines International Network and McMaster University (Ontario, Canada) in 2023.

...read more

Titles

  • Assistant Professor of Medicine

Departments / Divisions

Centers & Institutes

Education

Degrees

  • MD; Emory University School of Medicine (2007)

Residencies

  • Internal Medicine; Duke University School of Medicine (2010)

Fellowships

  • Gastroenterology and Hepatology; Johns Hopkins University School of Medicine (2013)
  • Transplant Hepatology; Johns Hopkins University School of Medicine (2015)

Board Certifications

  • American Board of Internal Medicine (Gastroenterology) (2013)
  • American Board of Internal Medicine (Internal Medicine) (2010)
  • American Board of Internal Medicine (Transplant Hepatology) (2016)

Research & Publications

Clinical Trial Keywords

Alcohol use disorder treatment; Liver transplant; Motivational intervention; Cognitive-behavioral therapy; Biomarker

Contact for Research Inquiries

Medical Office Coordinator
4940 Eastern Avenue, Suite A-502
Baltimore, MD 21224 map

Academic Affiliations & Courses

Courses and Syllabi

  • Mind and Brain
    Duke University Talent Identification Program
    2002 - 2002
  • Genes to Society - Gastroenterology/Hepatology
    Johns Hopkins School of Medicine
    2012
  • Inpatient Gastroenterology Service
    Johns Hopkins Hospital
    2013 - 2014
  • Inpatient Hepatology Service
    Johns Hopkins Hospital
    2015
  • Introduction to Clinical Research (PH.390.750)
    Johns Hopkins Bloomberg School of Public Health
    2019

Activities & Honors

Honors

  • Clinical Vignette Award, American College of Gastroenterology/AstraZeneca, 2011
  • Presidential Poster Award, American College of Gastroenterology, 2011
  • Grand Prize, Board Review Question of the Week, American College of Gastroenterology, 2012 - 2013
  • Faculty Teaching Award, Johns Hopkins Division of Gastroenterology & Hepatology, 2013 - 2014
  • Poster of Distinction, American Association for the Study of Liver Diseases, 2018
  • KL2 Clinical Research Scholar, Johns Hopkins Institute for Clinical and Translational Research, 2017 - 2020
  • Research Scholar Award, Gilead Sciences, 2020 - 2022
  • Clinician Scientist Award, Johns Hopkins University School of Medicine, 2020 - 2020
  • K23 Mentored Patient-Oriented Research Career Development Award, National Institute on Alcohol Abuse and Alcoholism, 2020 - 2025
  • Fellowship, American College of Gastroenterology, 2022
  • Clinical Research Leadership Program, American College of Gastroenterology, 2023 - 2024
  • Member, Delta Omega Honorary Society in Public Health, 2023

Memberships

  • American College of Gastroenterology, 2011
  • American Association for the Study of Liver Diseases, 2012
  • American Gastroenterological Association, 2016
  • International Liver Transplantation Society, 2019
  • Research Society on Alcoholism, 2020
  • Delta Omega Honorary Society in Public Health, 2023

Professional Activities

  • Continuing Medical Education Committee, American Association for the Study of Liver Diseases, 2019 - 2021
  • Steering Committee, Alcohol-associated Liver Disease Special Interest Group, American Association for the Study of Liver Diseases, 2021 - 2023
  • Medical Safety Officer, Non-Alcoholic Steatohepatitis Clinical Research Network, 2021
  • Practice Guidelines Committee, American Association for the Study of Liver Diseases, 2022 - 2024

Videos & Media

Lectures and Presentations

  • Fully covered self-expandable metallic stents for liver transplant-related biliary complications
    Speaker, Digestive Diseases Week, Orlando, Florida (05/01/2013)
    American Gastroenterological Association
  • Effects of chronic hepatitis C on pregnancy and perinatal outcomes
    Speaker, The Liver Meeting, Washington, DC (11/01/2013)
    American Association for the Study of Liver Diseases
  • Role of liver transplantation for alcoholic hepatitis: Should patients with acute alcoholic hepatitis be denied liver transplantation outright?
    Speaker, Digestive Diseases Week, Washington, DC (05/19/2015)
    American Gastroenterological Association
  • Psychosocial characteristics of patients with severe alcoholic hepatitis presenting for early liver transplantation evaluation
    Speaker, International Liver Transplantation Society 2019 Annual Congress, Toronto, Canada (05/01/2019)
    International Liver Transplantation Society
  • Alcoholic liver disease and liver transplantation
    Speaker, Medicine Grand Rounds (03/30/2018)
    MedStar Harbor Hospital
  • Early Liver Transplants for Patients with Severe Alcohol-Associated Liver Disease: Clinical Outcomes, Patient Experiences, and Public Perception
    Speaker, Transplant Management Forum, Denver, Colorado (05/17/2023)
    United Network for Organ Sharing

Recent News Articles and Media Coverage

PRO Study: NASH Tx Should Also Focus on Improved QOL—Advanced fibrosis tied negatively to multiple patient-reported outcomes, MedPage Today (February 19, 2019)

Destigmatizing Liver Transplant for Patients with Alcohol Use Disorder, Inside Tract (Winter 2021)

During pandemic, hospitals see rise in alcohol-related liver disease, NBC News (July 17, 2021)

5 Surprising Things to Know About Fatty Liver Disease, AARP Health (May 6, 2022)

The U.S.’s alcohol-induced death rate rose sharply in the pandemic’s first year, Science News (November 4, 2022)

Study Reveals High Prevalence of Alcohol, Opioid Use Among Patients with Crohn's Disease, Inside Hopkins (April, 10, 2023)

Johns Hopkins Among Few in U.S. to Offer Early Liver Transplants for Patients with Alcohol-Associated Liver Disease, Inside Tract (Spring 2023)

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Is this you? Edit Profile
back to top button